Harish Shantharam is Chief Financial Officer of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 75,000 shares of ALXO, which is worth approximately $81,750. The most recent transaction as insider was on Aug 18, 2025, when has been sold 75,000 shares (Common Stock) at a price of $0.78 per share, resulting in proceeds of $58,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75K
n/a 3M change
n/a 12M change
Total Value Held $81,750

Harish Shantharam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2025
BUY
Open market or private purchase
$58,500 $0.78 p/Share
75,000 Added 50.0%
75,000 Common Stock

Also insider at

CBAY
CymaBay Therapeutics, Inc. Healthcare
HS

Harish Shantharam

Chief Financial Officer
Newark, CA

Track Institutional and Insider Activities on ALXO

Follow ALX ONCOLOGY HOLDINGS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXO shares.

Notify only if

Insider Trading

Get notified when an Alx Oncology Holdings Inc insider buys or sells ALXO shares.

Notify only if

News

Receive news related to ALX ONCOLOGY HOLDINGS INC

Track Activities on ALXO